Taking aim at Ewing's sarcoma

Is KIT a target and will imatinib work?

Research output: Contribution to journalArticle

22 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)1660-1661
Number of pages2
JournalJournal of the National Cancer Institute
Volume94
Issue number22
StatePublished - Nov 20 2002

Fingerprint

Drug Dose Response Relationship
Piperazines
Proto-Oncogene Proteins c-kit
Cultured Tumor Cells
Bone Neoplasms
Pyrimidines
Clinical Trials, Phase I
Ewing's Sarcoma
Enzyme Inhibitors
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Antineoplastic Agents
Protein-Tyrosine Kinases
Imatinib Mesylate

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Taking aim at Ewing's sarcoma : Is KIT a target and will imatinib work? / Druker, Brian.

In: Journal of the National Cancer Institute, Vol. 94, No. 22, 20.11.2002, p. 1660-1661.

Research output: Contribution to journalArticle

@article{0c3f86b00a234b3e9d2b891c91f4bdce,
title = "Taking aim at Ewing's sarcoma: Is KIT a target and will imatinib work?",
author = "Brian Druker",
year = "2002",
month = "11",
day = "20",
language = "English (US)",
volume = "94",
pages = "1660--1661",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "22",

}

TY - JOUR

T1 - Taking aim at Ewing's sarcoma

T2 - Is KIT a target and will imatinib work?

AU - Druker, Brian

PY - 2002/11/20

Y1 - 2002/11/20

UR - http://www.scopus.com/inward/record.url?scp=0037146228&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037146228&partnerID=8YFLogxK

M3 - Article

VL - 94

SP - 1660

EP - 1661

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 22

ER -